| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $96.4M | +25.9% |
| SG&A Expense | $33.3M | +20.0% |
| Operating Income | -$129.7M | -24.4% |
| Income Tax | $0 | — |
| Net Income | -$124.7M | -29.9% |
| EPS (Basic) | -$3.06 | +36.6% |
| EPS (Diluted) | -$3.06 | +36.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $80.2M | +8.4% |
| Current Assets | $157.3M | +21.2% |
| Total Assets | $188.7M | +14.4% |
| Current Liabilities | $30.3M | +108.4% |
| Total Liabilities | $51.4M | +33.7% |
| Stockholders' Equity | $137.2M | +8.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$100.0M | -6.2% |
| Capital Expenditures | $654K | -56.8% |
| Investing Cash Flow | -$16.1M | -266.0% |
| Financing Cash Flow | $122.4M | +3821.7% |
| Free Cash Flow | -$100.7M | -5.2% |